REPAGLINIDE vs RESLIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REPAGLINIDE vs RESLIZUMAB: Safety Overview
| Metric | REPAGLINIDE | RESLIZUMAB |
|---|---|---|
| Total FAERS Reports | 2,544 | 621 |
| Deaths Reported | 169 | 15 |
| Death Rate | 6.6% | 2.4% |
| Hospitalizations | 1,517 | 121 |
| Average Patient Age | 71.9 yrs | 55.9 yrs |
| % Female Patients | 45.5% | 63.2% |
| FDA Approval Date | Apr 24, 2015 | N/A |
| Manufacturer | Rising Pharma Holdings, Inc. | Teva Respiratory, LLC |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Discontinued | Prescription |